期刊文献+

甲状腺球蛋白抗体对电化学发光免疫分析法测定甲状腺球蛋白的影响 被引量:12

Evaluation of Interference of Thyroglobulin Autoantibodies with Assay of Thyroglobulin Using Electrochemiluminescent Assay
原文传递
导出
摘要 采用电化学发光免疫分析法(ECLIA)同时测定甲状腺球蛋白(Tg)、自身甲状腺球蛋白抗体(TgAb)值,并用回收实验研究TgAb对Tg测定值的影响。甲状腺疾病患者血样84例,测定Tg、TgAb。回收实验分为三组。第一组分别加入50、100和200 ng/ml的标准Tg;第二组TgAb≥4 000 IU/ml的血样对倍稀释5次,分别测定Tg、TgAb值,并加入100 ng/ml标准Tg;第三组TgAb浓度梯度组,分别加入100 ng/ml标准Tg。计算回收率(R)。结果显示血清对倍稀释后,TgAb实测值逐渐下降;Tg实测值、Tg计算值逐渐上升,两者的差值随稀释倍数的增加而增大。当R<80%时,有22人(91.7%)TgAb>115 IU/ml。ECLIA测定Tg时,TgAb的干扰导致Tg测定值低于真实值,并呈浓度依赖性。TgAb的存在是导致回收率降低的主要原因。 Serum thyroglobulin(Tg) is primarily used as a tumor marker to detect the recurrent or persistent disease in patients with differentiated thyroid carcinomas.Unfortunately,the serum Tg measurement is technically challenging and the thyroglobulin autoantibody(TgAb) interference remain the most serious problem limiting the clinical value of serum Tg.The direction and magnitude of the interference are related to the method and the concentration and affinity of the TgAb in the specimen.The objective of this study was to evaluate TgAb's interference with assay of Tg by electrochemiluminescent assay(ECLIA).The Tg and TgAb of 84 sera were measured by the ECLIA.Recovery tests were carried out in 3 groups.3 different Tg calibrators,50,100,200 ng/ml,respectively,were added into the sera of the first group.The sera of second group were doubly diluted 5 times,and meawhile the Tg and TgAb were measured after each dilution,and then 100ng/ml Tg calibrator was added into the sera.The sera of third group were divided into different subgroups according to TgAb concentration and then 100ng/ml Tg calibrators were added.Recovery rate(%) was calculated.Tg value decreased when TgAb concentration increased by ECLIA,TgAb value became lower when sera were diluted,Tg value increased.The added Tg calibrator had not significant influence on Tg value and Recovery rate.Recovery rate was lower when TgAb concentration increased.When sera were diluted,the recovery rate was increased.Tg value were underestimated by TgAb interference.After sera were diluted,Tg value became increasing by ECLIA.The added Tg calibrator had not significantly influence on Tg value and Recovery rate.When sera were diluted,the recovery rate was increased.TgAb concentration had significant influence on Recovery rate.Rrecovery test can not efficiently rectify Tg value when TgAb was positive.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2011年第4期780-783,共4页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(30870724)
关键词 甲状腺球蛋白 自身甲状腺球蛋白抗体 分化型甲状腺癌 电化学发光免疫分析法 回收实验 Thyroglobulin(Tg) Thyroglobulin autoantibody(TgAb) Differentiated thyroid carcinomas(DTC) Electrochemiluminescent assay(ECLIA) Recovery test
  • 相关文献

参考文献14

  • 1FELDT-RASMUSSEN U, PROFILIS C, COLINET E, et al. Purification and assessment of stability and homogeneity of human thyroglobulin reference material (CRM457) [J]. Exp Clin Endocrinol, 1994,102:87.
  • 2DEMERS L M,SPENCER C A. Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease[J]. Thyroid, 2003, 13(1) : 57-67.
  • 3STANOJEVIC M,SAVIN S,CVEJI C D,et al. Correlation of thyroglobulin concentrations measured by radioimmunoassay and immunoradiometric assay and the influence of thyroglobulin antibody[J]. J Immunoassay Immunochem. 2009,30(2):197-207.
  • 4ERALI M,BIGELOW R B,MEIKLE A W. ELISA for thyorglobulin in serum: recovery studies to evaluate autoantibody interference and reliability of thyroglobulin values[J]. Clin Chem, 1996,42 : 766-770.
  • 5TORTAJADA-GENARO L A, ROMERO M. Immunoradiometric determination of thyroglobulin in serum samples by time calibration transfer[J]. Clin Chem Lab Med. 2008, 46 (10) : 1416-1422.
  • 6PONNUSAMY S, COLIN M. Thyroid autoantibody[J]. Endocrinol Metab Clin North Am, 2001,30(2) :315-337.
  • 7沈江帆,张乃康,方云华,白春华.自身甲状腺球蛋白抗体阳性时三种测定甲状腺球蛋白浓度方法比较[J].标记免疫分析与临床,2002,9(4):219-221. 被引量:4
  • 8王金果,林向阳,吴永根,周武.血清甲状腺自身抗体对甲状腺球蛋白测定的影响[J].中国实验诊断学,2007,11(5):662-663. 被引量:6
  • 9KRAHNJ, DEMBINSKI T. Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring[J].Clin Biochem, 2009,42(4-5) :416-419.
  • 10SPENCER C A, BERGOGLIO L M, KAZAROSYAN M, et al. Clinical impact of thyroglobulln (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas [J]. J Clin Endoerinol Metab, 2005,90(10) :5566-5575.

二级参考文献13

共引文献13

同被引文献83

  • 1马立驰.胜利油田下古生界碳酸盐岩潜山勘探核心技术[J].石油勘探与开发,2005,32(2):72-74. 被引量:11
  • 2李玉姝,单忠艳,关海霞,金迎,滕晓春,胡凤楠,杨帆,于晓会,范晨玲,李晨阳,滕卫平.甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阳性临界值的确定及其临床意义[J].中华检验医学杂志,2006,29(9):780-783. 被引量:50
  • 3秦建强,赵军龙,李新胜,李娜,刘来祥.陕北姬塬油区储集层特征地球物理测井分析[J].特种油气藏,2007,14(3):32-34. 被引量:3
  • 4National Cancer Institute. SEER cancer statistics factsheets: thyroid cancer [ R/OL ]. http : //seer. cancer, gov/staffacts/ html/thyro, html.
  • 5Rahmoun MN, Bendahmane 1. Anti-thyroglobulin antibodies in differentiated thyroid carcinoma patients : study of the clin- ical and biological, parameters [ J]. Ann Endocrinol ( Paris), 2014, 75(1):15-18.
  • 6Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thy- roglobulin autoantibodies : prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma [ J]. J Clin En- docrinol Metab, 1998, 83 (4) : 1121-1127.
  • 7Durante C, Tognini S, Montesano T, et al. Clinical aggres- siveness and long-term outcome in patients with papillary thy- roid cancer and circulating anti-thyroglobuhn autoantibodies [J]. Thyroid, 2014, 24(7):1139-1145.
  • 8Tsushima Y, Miyauchi A, ho Y, et al. Prognostic signifi- cance of changes in serum thyrogtobulin antibody levels of pre-and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients [ J ] Endocrine J, 2013, 60(7) :871-876.
  • 9Seo JH, Lee SW, Ahn BC, et al. Recurrerce detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody : special emphasis on using (18) F-FDG PET/CT [ J ]. Clin Endocrinol, 2010, 72 ( 4 ) : 558-563.
  • 10Smooke-Praw S, Ro K, Levin O, et al. Thyroglobulin anti- body levels do not predict disease status in papillary thyroid cancer [J]. Clin Endocrinol, 2014, 81(2):271-275.

引证文献12

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部